Filippo Mastropasqua

Filippo Mastropasqua

Auto-generated profile, based on publicly available information

Filippo Mastropasqua

Salvatore Maugeri Foundation, Institute for Clinical Care and Research (IRCCS), Scientific Institute of Cassano Murge, Bari, Italy

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2002 in JACC
Verified
Journal Article
Closed access
MPMaria Vittoria Pitzalis
Maria Vittoria Pitzalis
MIMassimo Iacoviello
Massimo Iacoviello
RRRoberta Romito
Roberta Romito
FMFrancesco Massari
Francesco Massari
BRBrian Rizzon
Brian Rizzon
PRPaolo Rizzon
Paolo Rizzon

14 April 1998 in Circulation
Verified
Journal Article
Closed access
PDF file
MPMaria Vittoria Pitzalis
Maria Vittoria Pitzalis
FMFilippo Mastropasqua
Filippo Mastropasqua
APAndrea Passantino
Andrea Passantino
FMFrancesco Massari
Francesco Massari
LLLuana Ligurgo
Luana Ligurgo
PRPaolo Rizzon
Paolo Rizzon
Background—Depressed baroreflex sensitivity obtained by means of a phenylephrine test plays a prognostic role in patients with a previous myocardial infarction. Our purpose was to evaluate the correlation and agreement between the baroreflex sensitivity obtained with phenylephrine and that obtained by two noninvasive methods: the α-index and sequence analysis.Methods and Results—The α-index was measured by means of the spectral analysis of RR and systolic blood pressure variabilities in both the high- and low-frequency bands; sequences were identified from simultaneously recorded time series in which the RR and systolic blood pressure concurrently increased or decreased. Noninvasive baroreflex sensitivity tests were performed during both spontaneous and controlled respiration. Fifty-two consecutive patients with recent myocardial infarction underwent the analyses. Although the correlations between phenylephrine and either of the noninvasive methods were always significant, those found during controlled respiration had the highestrvalues (r=.70). However, the limits of agreement calculated by means of the Bland and Altman method were wide for both noninvasive methods.Conclusions—The results obtained by means of noninvasive baroreflex sensitivity assessments should not be used in clinical practice as an alternative to those obtained by the phenylephrine method.

1 August 1996 in Cardiovascular Research
Verified
Journal Article
Closed access
MPM V Pitzalis
M V Pitzalis
FMF Mastropasqua
F Mastropasqua
FMF Massari
F Massari
CFCinzia Forleo
Cinzia Forleo
MMM Di Maggio
M Di Maggio
PRP Rizzon
P Rizzon
To obtain data relating to the reproducibility of the time and frequency domain measurements obtained from 10-min ECG recordings. Eighteen normal volunteers underwent evaluations of time and frequency domain heart rate variability 2 weeks and 7 months after baseline analysis. The time domain parameters were mean NN, the standard deviation of NN intervals, the percentage of successive NN intervals > 50 ms and the root mean square successive difference of NN intervals. The frequency domain evaluations (total power, low frequency, and high frequency) were made by means of both the Fast Fourier Transform algorithm (FFT) and the autoregressive method (AR) from 10-min ECG recordings made under three different conditions: rest, controlled respiration, and after a passive head-up tilt test. Reproducibility was evaluated by means of the interclass correlation coefficient (ICC), comparing baseline values with the results obtained at the second week and the seventh month. Time domain evaluation were also made from 10-min ECG. All of the time domain measurements had an ICC > or = 0.75, except for the standard deviation of NN intervals, which had an ICC of 0.57. The frequency domain parameters obtained by means of either FFT or AR showed similar reproducibility. Low frequency was reproducible under all three conditions, total power only at rest, and high frequency only during controlled respiration. The reproducibility of frequency domain parameters depends on the analysed condition. These results are of primary importance when the effects of drugs or other interventions on heart rate variability are under investigation.

1 July 2006 in JACC
Verified
Journal Article
Closed access
APAndrea Passantino
Andrea Passantino
RLRocco Lagioia
Rocco Lagioia
FMFilippo Mastropasqua
Filippo Mastropasqua
DSDomenico Scrutinio
Domenico Scrutinio

1 November 2003 in JACC
Verified
Journal Article
Closed access
MPMaria Vittoria Pitzalis
Maria Vittoria Pitzalis
MAMatteo Anaclerio
Matteo Anaclerio
MIMassimo Iacoviello
Massimo Iacoviello
CFCinzia Forleo
Cinzia Forleo
PGPietro Guida
Pietro Guida
PRPaolo Rizzon
Paolo Rizzon

1 December 2017 in Stroke
Verified
Journal Article
Open access
PDF file
DSDomenico Scrutinio
Domenico Scrutinio
BLBernardo Lanzillo
Bernardo Lanzillo
PGPietro Guida
Pietro Guida
FMFilippo Mastropasqua
Filippo Mastropasqua
VMVincenzo Monitillo
Vincenzo Monitillo
GCGianluigi Calabrese
Gianluigi Calabrese
Background and Purpose—: Prediction of outcome after stroke rehabilitation may help clinicians in decision-making and planning rehabilitation care. We developed and validated a predictive tool to estimate the probability of achieving improvement in physical functioning (model 1) and a level of independence requiring no more than supervision (model 2) after stroke rehabilitation. Methods—: The models were derived from 717 patients admitted for stroke rehabilitation. We used multivariable logistic regression analysis to build each model. Then, each model was prospectively validated in 875 patients. Results—: Model 1 included age, time from stroke occurrence to rehabilitation admission, admission motor and cognitive Functional Independence Measure scores, and neglect. Model 2 included age, male gender, time since stroke onset, and admission motor and cognitive Functional Independence Measure score. Both models demonstrated excellent discrimination. In the derivation cohort, the area under the curve was 0.883 (95% confidence intervals, 0.858–0.910) for model 1 and 0.913 (95% confidence intervals, 0.884–0.942) for model 2. The Hosmer–Lemeshow χ 2 was 4.12 ( P =0.249) and 1.20 ( P =0.754), respectively. In the validation cohort, the area under the curve was 0.866 (95% confidence intervals, 0.840–0.892) for model 1 and 0.850 (95% confidence intervals, 0.815–0.885) for model 2. The Hosmer–Lemeshow χ 2 was 8.86 ( P =0.115) and 34.50 ( P =0.001), respectively. Both improvement in physical functioning (hazard ratios, 0.43; 0.25–0.71; P =0.001) and a level of independence requiring no more than supervision (hazard ratios, 0.32; 0.14–0.68; P =0.004) were independently associated with improved 4-year survival. A calculator is freely available for download at https://goo.gl/fEAp81 . Conclusions—: This study provides researchers and clinicians with an easy-to-use, accurate, and validated predictive tool for potential application in rehabilitation research and stroke management.